Schulz, L., Leerhoff, S., Kolbe, E., Raem, A. M., & Winde, G. (2022). Methylated septin 9 as a progression parameter in colorectal cancer compared to CEA and CA19-9. Oncology research and treatment. https://doi.org/10.1159/000521004
Chicago-Zitierstil (17. Ausg.)Schulz, Laura, Sabine Leerhoff, Ernst-Wolfgang Kolbe, Arnold M. Raem, und Günther Winde. "Methylated Septin 9 as a Progression Parameter in Colorectal Cancer Compared to CEA and CA19-9." Oncology Research and Treatment 2022. https://doi.org/10.1159/000521004.
MLA-Zitierstil (8. Ausg.)Schulz, Laura, et al. "Methylated Septin 9 as a Progression Parameter in Colorectal Cancer Compared to CEA and CA19-9." Oncology Research and Treatment, 2022, https://doi.org/10.1159/000521004.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.